RNA sequencing studies indicate that SPAG4 overexpression activates the lipogenesis state and the SREBP1-mediated pathway, providing evidence for its role in lipid metabolism dysregulation and tumor progression in hepatocellular carcinoma (Liu et al., 2022). This evidence concerns the gene SPAG4 and hepatocellular carcinoma.